Is the Biotech Party Over?
Should investors bail out of biotech, which has lost almost 25% since late July, or short the sector?
Top Portfolio Products: Schwab Adds Commission-Free ETFs
There are more choices than ever for investing overseas, from ETFs that hedge currency exposure to funds that focus on sustainability.
Why SEC Is Cracking Down on 12b-1 Fees and ‘Distribution-in-Guise’
Once again, the SEC provides "guidance" to advisors in the form of an enforcement action, this time a $40 million judgment against First Eagle.
The ETF Generation Gap
"Millennials are doubling down on ETFs," says Schwab’s Heather Fischer.
The Low-Growth World Ahead: Vanguard’s Chief Economist
Slow global growth will be “the defining trend of our lifetime,” says Joe Davis, Vanguard’s chief economist.
Rating the 401(k) of the Fund Rater
Employers that fill their retirement plans with active fund managers encourage the kind of bad investor choices that lead to underperformance.
SEC Wants to ‘Keep Alive’ the ’40 Acts Through New Regs; Bogle Talks ETFs
At 75th anniversary event, Vanguard founder John Bogle and T. Rowe Price’s James Riepe debate ETF regulation; SEC Chief White talks about upcoming rules.
Morningstar to Tackle Hottest ETF Topics at Conference
Among the topics where Morningstar wants to "rethink conventional wisdom" are active share, strategic beta, 401(k) mistakes and hedging currency exposure.
3 Keys to Picking Active Retirement Investments: American Funds
Actively managed equity funds that met these three criteria historically generated more wealth for retirees compared with index portfolios, according to American Funds.
Top Portfolio Products: International Funds From Vanguard, T. Rowe Price
How two different mega fund companies hope to profit from investing in international stocks